FDA considers half-dose of Moderna vaccine as a booster

The Food and Drug Administration is leaning towards approving a half-dose of Moderna’s COVID-19 vaccine as a booster injection, according to a report.

The agency is confident the dosage level would provide sufficient protection against the virus, people familiar with the matter told Bloomberg News.

MODERNA CEO SAYS COVID-19 PANDEMIC COULD BE ENDED WITHIN A YEAR

Moderna had pushed for the half-dose in its recall request submitted to federal regulators on September 1.

The drug manufacturer’s original vaccine contains 100 micrograms of mRNA in each injection.

This file photo from June 14, 2021 shows a vial of Moderna COVID-19 vaccine that is administered to flight attendants of Japan Airlines at Haneda Airport in Tokyo. Japan’s health ministry said on Thursday August 26, 2021 it was suspending the use of abo (AP Photo / Eugene Hoshiko / AP Newsroom)

By comparison, Pfizer has 30 micrograms in its initial and booster doses, according to the report.

CLICK HERE TO LEARN MORE ABOUT FOX BUSINESS

The FDA has approved Pfizer’s recall for people over 65 and those over 18 and have an underlying health condition that makes them more susceptible to the disease, or who are at high risk of contracting the disease. the virus from their work. such as health workers and teachers.

The Centers for Disease Control and Prevention currently recommends that people receive their recalls from the same drug manufacturer as their original doses.